Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

MDS 2022 | Understanding patient perceptions of medication adherence in PD

Michelle Tosin, PhD, MSN, RN, Rush University Medical Center, Chicago, IL, shares the results of an international study assessing how patients with Parkinson’s disease (PD) and their care partners describe medication adherence. The exploratory qualitative and multicenter study was conducted using focus group approach in two international outpatient clinics specialized in movement disorders in Brazil and the United States. Results indicated that medication adherence in PD is subdivided into 14 domains. All participants experienced more than one domain of medication adherence, and the most common phenomena were “”Positive therapeutic behaviors””, “”Complex therapeutic regimen””, “”Barriers to treatment access”” and “”Perception of the effect of the drug””. These results were used to develop The Parkinson’s Disease Medication Adherence Scale (PD-MAS). This interview took place at the 2022 International Congress of Parkinson’s Disease and Movement Disorders in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.